These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3160322)

  • 21. [Laboratory and clinical studies on cefoxitin in pediatric field (author's transl)].
    Iwai N; Sasaki A; Taneda Y; Osuga T; Inokuma K
    Jpn J Antibiot; 1981 Mar; 34(3):287-304. PubMed ID: 7289022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparative human pharmacokinetics of cefazolin and cefoxitin using high-performance liquid chromatography (author's transl)].
    Brisson AM; Fourtillan JB; Barthes D; Courtois P; Becq-Giraudon B
    Therapie; 1980; 35(2):209-20. PubMed ID: 7414530
    [No Abstract]   [Full Text] [Related]  

  • 23. Relevance of serum protein binding of cefoxitin and cefazolin to their activities against Klebsiella pneumoniae pneumonia in rats.
    Bakker-Woudenberg IA; van den Berg JC; Vree TB; Baars AM; Michel MF
    Antimicrob Agents Chemother; 1985 Nov; 28(5):654-9. PubMed ID: 3911879
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cefamandole and cefoxitin.
    Sanders CV; Greenberg RN; Marier RL
    Ann Intern Med; 1985 Jul; 103(1):70-8. PubMed ID: 3890658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interstitial fluid concentrations of cefoxitin, cephazolin and cefamandole.
    Landau Z; Rubinstein E; Halkin H
    J Antimicrob Chemother; 1980 Sep; 6(5):657-63. PubMed ID: 7410286
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison of the pharmacokinetics of cephradine and cefazolin in pregnant and non-pregnant women.
    Philipson A; Stiernstedt G; Ehrnebo M
    Clin Pharmacokinet; 1987 Feb; 12(2):136-44. PubMed ID: 3829560
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Penetration of moxalactam and cefazolin into atrial appendage after simultaneous intramuscular or intravenous administration.
    Polk RE; Smith JE; Ducey K; Lower RR
    Antimicrob Agents Chemother; 1982 Aug; 22(2):201-3. PubMed ID: 6927281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interference by cephalosporins with creatinine measurement by desk-top analyzers.
    Nanji AA; Poon R; Hinberg I
    Eur J Clin Pharmacol; 1987; 33(4):427-9. PubMed ID: 3443149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum and tissue concentrations of cefoxitin and cefamandole in women undergoing hysterectomy.
    French MA; Quintiliani R; Nightingale CH; Russo JN
    Obstet Gynecol; 1983 Jan; 61(1):42-7. PubMed ID: 6823348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cefoxitin versus erythromycin, neomycin, and cefazolin in colorectal operations. Importance of the duration of the surgical procedure.
    Kaiser AB; Herrington JL; Jacobs JK; Mulherin JL; Roach AC; Sawyers JL
    Ann Surg; 1983 Oct; 198(4):525-30. PubMed ID: 6354113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Penetration of clindamycin, cefoxitin, and piperacillin into pancreatic juice in man.
    Brattström C; Malmborg AS; Tydén G
    Surgery; 1988 May; 103(5):563-7. PubMed ID: 3283981
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does intraoperative blood loss affect antibiotic serum and tissue concentrations?
    Swoboda SM; Merz C; Kostuik J; Trentler B; Lipsett PA
    Arch Surg; 1996 Nov; 131(11):1165-71; discussion 1171-2. PubMed ID: 8911256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of sodium ampicillin, sodium cefazolin, and sodium cefoxitin on blood pressures and heart rates in healthy, anesthetized dogs.
    Morgan MR; Gaynor JS; Monnet E
    J Am Anim Hosp Assoc; 2000; 36(2):111-4. PubMed ID: 10730619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disposition of cefoxitin in patients with pleural effusion.
    Barrueco M; Garcia MJ; Otero MJ; Dominguez-Gil A; de Letona JM
    Clin Ther; 1981; 3(6):425-35. PubMed ID: 7260988
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of cefazolin and cefuroxime tissue penetration by using a continuous intravenous infusion.
    Connors JE; DiPiro JT; Hayter RG; Hooker KD; Stanfield JA; Young TR
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1128-31. PubMed ID: 2393271
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum cefazolin levels during spinal fusion: effect of blood loss and duration of surgery.
    Lopez-Sosa FH; Polly D; Bowen JR; Eppes SC; Klein JD; St John KH; Corddry DH
    J Spinal Disord; 1993 Aug; 6(4):296-9. PubMed ID: 8219543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of lidocaine on the absorption, disposition and tolerance of intramuscularly administered cefoxitin.
    Sonneville PF; Albert KS; Skeggs H; Gentner H; Kwan KC; Martin CM
    Eur J Clin Pharmacol; 1977 Dec; 12(4):273-9. PubMed ID: 590313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Laboratory and clinical studies of cefoxitin in pediatric infections (author's transl)].
    Nishikawa K; Aso K; Miyachi Y; Ogawa A; Kuno K; Kondo K
    Jpn J Antibiot; 1981 Mar; 34(3):279-86. PubMed ID: 7289021
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics and body fluid and endometrial concentrations of cefoxitin in mares.
    Brown MP; Gronwall RR; Houston AE
    Am J Vet Res; 1986 Aug; 47(8):1734-8. PubMed ID: 3752682
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics and tissue concentrations of cefazolin in pediatric patients undergoing gastrointestinal surgery.
    Nahata MC; Durrell DE; Ginn-Pease ME; King DR
    Eur J Drug Metab Pharmacokinet; 1991; 16(1):49-52. PubMed ID: 1936061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.